Related Experiment Video
Updated: Feb 4, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
1Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia, matej.sova@ffa.uni-lj.si.
Abstract:
A major cell defense mechanism against oxidative and xenobiotic stress is mediated by the Nrf2/Keap1 signaling pathway. The Nrf2/Keap1 pathway regulates gene expression of many cytoprotective and detoxifying enzymes, thus playing a pivotal role in maintaining redox cellular homeostasis. Many diseases including cancer have been closely related to impaired Nrf2 activity. Targeting Nrf2 and modulating its activity represents a novel modern strategy for cancer chemoprevention and therapy. In this review, different design strategies used for the development of Nrf2 modulators are described in detail. Moreover, the main focus is on important and recently developed Nrf2 activators and inhibitors, their in vitro and in vivo studies, and their potential use as chemopreventive agents and/or cancer therapeutics.
Insights
The Nrf2/Keap1 pathway protects cells from stress and is crucial for cancer therapy. This review details Nrf2 modulators, activators, and inhibitors for cancer chemoprevention and treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- The Nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) pathway is a critical cellular defense against oxidative and xenobiotic stress.
- This pathway regulates the expression of numerous cytoprotective and detoxifying enzymes, maintaining cellular redox homeostasis.
- Dysregulation of Nrf2 activity is implicated in various diseases, notably cancer.
Purpose of the Study:
- To review design strategies for developing Nrf2 modulators.
- To highlight recent advancements in Nrf2 activators and inhibitors.
- To discuss the potential of Nrf2 modulators in cancer chemoprevention and therapy.
Main Methods:
- Literature review of Nrf2/Keap1 pathway research.
- Analysis of design strategies for Nrf2 modulators.
- Summary of in vitro and in vivo studies on Nrf2 activators and inhibitors.
Main Results:
- Detailed description of various design strategies for Nrf2 modulators.
- Identification of key Nrf2 activators and inhibitors with recent development.
- Compilation of evidence from in vitro and in vivo studies.
Conclusions:
- Targeting the Nrf2 pathway offers a promising strategy for cancer chemoprevention and treatment.
- Nrf2 modulators, including activators and inhibitors, show potential as therapeutic agents.
- Further research into Nrf2 modulators could lead to novel cancer therapies.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Group Design
Gene Therapy

